Anthony Rodgers's Publications

About Anthony Rodgers's Publications

Professorial Fellow, Professoriate
  • Professor of Global Health, Faculty of Medicine, UNSW Sydney
  • Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London

  • CPAP treatment on depression and anxiety symptoms in OSA patients: a SAVE study and meta-analysis

    Date published:

  • Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trial

    Antiviral Therapy Date published:

  • More Intensive LDL-C Lowering Reduces Major Vascular Events Beyond Current Recommendations: Systematic Review and Meta-Analysis

    Heart, Lung and Circulation Date published:

  • Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus

    Hypertension Date published:

  • Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean

    Journal of Hypertension Date published:

  • Regression to the mean of repeated ambulatory blood pressure monitoring in five studies

    Journal of Hypertension Date published:

  • Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

    The Lancet HIV Date published:

  • PO263 Choice In Blood Pressure Lowering Drug Therapy - An Analysis of the Availability of Different Drugs and Doses Over the Last 40 Years

    Global Heart Date published:

  • Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India

    BMC Public Health Date published:

  • 543. An Integrated Safety Analysis Comparing Once-Daily Doravirine (DOR) to Darunavir+Ritonavir (DRV+r) and Efavirenz (EFV) in HIV-1-Infected, Antiretroviral Therapy (ART)-Naïve Adults

    Open Forum Infectious Diseases Date published:

  • Fixed-dose combinations for hypertension

    The Lancet Date published:

  • Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial

    Clinical Infectious Diseases Date published:

  • Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative study

    BMJ Open Date published:

  • Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka

    JAMA: The Journal of the American Medical Association Date published:

  • Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial

    International Journal of Cardiology Date published:

  • Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

    The Lancet Diabetes & Endocrinology Date published: